CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Salt Lake City, Utah, United States and 13 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Salt Lake City, Utah, United States and 145 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Murray, Utah, United States and 54 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 112 other locations
the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...
Phase 1
Salt Lake City, Utah, United States and 15 other locations
compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...
Phase 3
Murray, Utah, United States and 247 other locations
This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...
Phase 2
Salt Lake City, Utah, United States
second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...
Phase 3
Salt Lake City, Utah, United States and 218 other locations
The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatme...
Phase 2
Salt Lake City, Utah, United States
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate ca...
Phase 2
Salt Lake City, Utah, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal